|
Indianapolis, Ind. August 18, 2004
Roche Diagnostics Terminates Its Agreement With Hock's Vandalia
Pharmacy
Product Distribution Method Incongruent With Contractual Terms
& Conditions
Roche Diagnostics Corporation today announced that it has terminated
its Durable Medical Equipment (DME) Agreement with Hock's Vandalia
Pharmacy. The termination of the relationship resulted from the
discovery of the use of product distribution methods that did not
comply with the terms and conditions of the agreement.
"Roche Diagnostics is committed to ensuring that those products
intended for a particular class of trade are distributed to the
appropriate end-user," stated Daniel Kane, Vice President of
Consumer Sales, Diabetes Care, Roche Diagnostics. "To assist
with that objective, we implemented a formalized audit process to
monitor customer compliance with the terms and conditions of our
contracts. As a result of this process, Roche Diagnostics decided
it should terminate this customer contract as it has done over the
past year with other DME suppliers for noncompliance related to
product distribution methods."
Roche Diagnostics is not in the position to release additional
information about other DME supplier contract terminations.
About Roche and the Roche Diagnostics Division
Headquartered in Basel, Switzerland, Roche is one of the world's
leading innovation-driven healthcare groups. Its core businesses
are pharmaceuticals and diagnostics. Roche is number one in the
global diagnostics market, the leading supplier of pharmaceuticals
for cancer, and a leader in virology and transplantation. As a supplier
of products and services for the prevention, diagnosis, and treatment
of disease, the Group contributes on a broad range of fronts to
improving people's health and quality of life. Roche employs approximately
62,000 people in 150 countries. The Group has alliances and research
and development agreements with numerous partners, including majority
ownership interests in Genentech and Chugai. Roche's Diagnostics
Division, the world leader in in-vitro diagnostics with a uniquely
broad product portfolio, supplies a wide array of innovative testing
products and services to researchers, physicians, patients, hospitals,
and laboratories worldwide. Roche Diagnostics' North American headquarters
is located in Indianapolis, Ind. (www.roche-diagnostics.us).
For further information, please visit our websites www.roche.com
and www.roche-diagnostics.com.
For more information please contact:
Lori LeRoy
Roche Diagnostics Corporation
317-521-9157
lori.leroy@roche.com
ACCU-CHEK is a trademark of a member of The Roche Group.
|
